Get API access

Novo Nordisk sues Eli Lilly over weight-loss drug advertising claims

10 statements, Jul 24, 2026 08:47 UTC to Sep 22, 2026 19:38 UTC
NewsAnalysis
Created
Updated
LLYNVONOVOLIVLIL
All topics

Statements (10)

  1. Bearish

    Hundreds of consumers are suing GLP-1 drug makers over vision loss claims

    foxnews.comHigh importance
  2. Bearish

    Novo Nordisk lost its GLP-1 lead to Eli Lilly & Co.

    zerohedge.comHigh importance
  3. Neutral

    Novo Nordisk is escalating a lawsuit against Eli Lilly over obesity treatment marketing

    finance.yahoo.com
  4. Bearish

    Eli Lilly is suing pharmacies and peptide vendors over sale of retatrutide

    marketwatch.comHigh importance
  5. Bearish

    Novo Nordisk A/S filed a lawsuit in U.S. federal court against Eli Lilly and Company

    finance.yahoo.comHigh importance
  6. Bullish

    Lilly and Novo Nordisk won an antitrust lawsuit over access to compounded GLP-1 drugs.

    finance.yahoo.comHigh importance
  7. Neutral

    Eli Lilly and Novo Nordisk may see increased market confidence as they secure a legal victory in the GLP-1 antitrust dispute.

    finance.yahoo.com
  8. Neutral

    Novo Nordisk sued Eli Lilly over GLP-1 drug advertising claims.

    finance.yahoo.com
  9. Neutral

    Novo Nordisk sues Eli Lilly over weight-loss drug ads comparing their products.

    finance.yahoo.com
  10. Neutral

    Novo Nordisk is seeking a preliminary U.S. court injunction to block Eli Lilly's weight-loss drug advertisements

    yahoo.comHigh importance